We use Artificial Intelligence to:

Discover insightful robust omics biomarkers

Make early cancer diagnosis a routine

 

                                                                                                                                                        © Wright Studio, Shutterstock


WHO WE ARE

We are an AI-driven Biomedical Data Science Company. We have an interdisciplinary team, backed by key opinion leaders.

 

Artificial Intelligence Expert (AIE) and ONCOPREDICT (OP) are spin-off companies of Solutions of Artificial Intelligence Applications (SAIA)  research organization. 


AIE & OP

What we offer:

Starting with a routine blood draw (Liquid Biopsy) and applying advanced Artificial Intelligence (Machine Learning and Deep Learning) on the most relevant molecular alterations, we developed the best test for multi-cancer diagnosis and early detection diagnosis. It works on 13 cancer types.  

 

Our universal AI platform extracts highly accurate predictive models from omics data, for diagnosis, prognosis, and response to treatment.


Cancer Tests

Learn more about the cancer tests.

Research

Find out more about our research progress and projects that imply us.

Services

Omics data analysis services with AI.


Read the latest news about our company

If you want to find details about our most recent endeavors visit our news tab:

Partners & collaborators:


LET US Evolve YOUR BUSINESS

GET IN TOUCH

For additional information please contact us !

Note: Please fill out the fields marked with an asterisk.